Business Description
Shanghai Medicilon Inc
ISIN : CNE100003NQ8
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.29 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | -0.86 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 5.65 | |||||
Beneish M-Score | 14.1 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.9 | |||||
3-Year EBITDA Growth Rate | -33.8 | |||||
3-Year Book Growth Rate | 26.3 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.25 | |||||
9-Day RSI | 46.14 | |||||
14-Day RSI | 48.96 | |||||
6-1 Month Momentum % | 20.54 | |||||
12-1 Month Momentum % | -46.58 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.84 | |||||
Quick Ratio | 2.64 | |||||
Cash Ratio | 1.21 | |||||
Days Inventory | 54.74 | |||||
Days Sales Outstanding | 240.32 | |||||
Days Payable | 61.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.5 | |||||
Shareholder Yield % | 1.54 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 0.96 | |||||
Operating Margin % | -28.35 | |||||
Net Margin % | -28.12 | |||||
FCF Margin % | -14.05 | |||||
ROE % | -11.16 | |||||
ROA % | -8.74 | |||||
ROIC % | -10.85 | |||||
ROC (Joel Greenblatt) % | -23.95 | |||||
ROCE % | -13 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 16.47 | |||||
Shiller PE Ratio | 36.99 | |||||
PS Ratio | 4.97 | |||||
PB Ratio | 2.08 | |||||
Price-to-Tangible-Book | 2.36 | |||||
EV-to-EBIT | -14.03 | |||||
EV-to-EBITDA | -14.03 | |||||
EV-to-Revenue | 4.73 | |||||
EV-to-FCF | -33.4 | |||||
Price-to-Projected-FCF | 4.44 | |||||
Price-to-Net-Current-Asset-Value | 5.2 | |||||
Price-to-Net-Cash | 84.3 | |||||
Earnings Yield (Greenblatt) % | -7.13 | |||||
FCF Yield % | -2.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shanghai Medicilon Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 984.166 | ||
EPS (TTM) (Â¥) | -2.15 | ||
Beta | 1.95 | ||
Volatility % | 71.07 | ||
14-Day RSI | 48.96 | ||
14-Day ATR (Â¥) | 2.360884 | ||
20-Day SMA (Â¥) | 37.777 | ||
12-1 Month Momentum % | -46.58 | ||
52-Week Range (Â¥) | 23.3 - 73.85 | ||
Shares Outstanding (Mil) | 134.67 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shanghai Medicilon Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shanghai Medicilon Inc Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Shanghai Medicilon Inc Frequently Asked Questions
What is Shanghai Medicilon Inc(SHSE:688202)'s stock price today?
When is next earnings date of Shanghai Medicilon Inc(SHSE:688202)?
Does Shanghai Medicilon Inc(SHSE:688202) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |